EJHaem

Keyphrases

Publications

volume 5, number 4, 2024

Akshay Deshpande, Dina Osman, Vidhya Murthy, Hayder Hussein
Extramedullary chronic phase chronic myeloid leukaemia (CML) involving the central nervous system: A case report. EJHaem 5 (4) (2024)
Alexandra E Rojek, Benjamin J McCormick, Joanna Cwykiel, Oluwatobi Odetola, Yasmin Abaza, Nhi Nai, Charles E Foucar, Rohan K Achar, Rory M Shallis, Danielle Bradshaw, Meaghan Standridge, Vamsi Kota, Guru Subramanian Guru Murthy, Talha Badar, Anand Ashwin Patel
Real-world outcomes of intensive induction approaches in core binding factor acute myeloid leukemia. EJHaem 5 (4) (2024)
Enrico Schalk
Immune effector cell-associated haemophagocytic lymphohistiocytosis-like syndrome. EJHaem 5 (4) (2024)
Christopher Shwei Wen Tham, Jeffrey Quek, Yeh Ching Linn, Lawrence Ng, Aloysius Ho, Francesca Lim, Yunxin Chen, Chandramouli Nagarajan, William Ying Khee Hwang, Jing Jing Lee, Gina Gan, Shimin Jasmine Chung, Ban Hock Tan, Thuan Tong Tan, Hein Than
Implications of acute coronavirus disease 2019 during haematopoietic stem cell transplantation-Experience from real-world clinical practice. EJHaem 5 (4) (2024)
Yohei Funakoshi, Kimikazu Yakushijin, Goh Ohji, Takaji Matsutani, Kazuhiko Doi, Hironori Sakai, Tomoki Sasaki, Takahiro Kusakabe, Sakuya Matsumoto, Yasuyuki Saito, Shinichiro Kawamoto, Katsuya Yamamoto, Taiji Koyama, Yoshiaki Nagatani, Keiji Kurata, Shiro Kimbara, Yoshinori Imamura, Naomi Kiyota, Mitsuhiro Ito, Hironobu Minami
Analysis of B-cell receptor repertoire to evaluate immunogenicity of monovalent Omicron XBB.1.5 mRNA vaccines. EJHaem 5 (4) (2024)
Toshiki Terao, Takumi Kondo, Makoto Nakamura, Hiroki Takasuka, Hideaki Fujiwara, Noboru Asada, Daisuke Ennishi, Hisakazu Nishimori, Keiko Fujii, Nobuharu Fujii, Yoshinobu Maeda, Ken-Ichi Matsuoka
Combination of reduced post-transplant cyclophosphamide and early tacrolimus initiation increases the incidence of chronic graft-versus-host disease in human leukocyte antigen-haploidentical peripheral blood stem-cell transplantation. EJHaem 5 (4) (2024)
Yusuke Takada, Shuhei Kurosawa, Toshimitsu Ueki, Yuho Najima, Satoshi Wakita, Hiroki Yamaguchi, Takako Yokota, Masaki Hibi, Ayumi Hirahara, Tsutomu Yoshida, So Okubo, Moe Masuda, Hitomi Nakayama, Aki Sakurai, Chisako Ito, Yoshinobu Aisa, Tomonori Nakazato
Overcoming post-transplant graft failure and adenovirus infection in a patient with FLT3 -TKD-mutated mixed-phenotype acute leukemia: A case report. EJHaem 5 (4) (2024)
Monique C Minnema, Kazem Nasserinejad, Ute Hegenbart, Paula F Ypma, Ka Lung Wu, Marie José Kersten, Sandra Croockewit, Sonja Zweegman, Lidwine W Tick, Annemiek Broijl, Harry Koene, Gerard M J Bos, Pieter Sonneveld, Stefan O Schönland
HOVON 104, long-term follow-up of bortezomib-dexamethasone induction therapy followed by autologous stem cell transplantation in newly diagnosed AL amyloidosis patients. EJHaem 5 (4) (2024)
Quentin Vô, Mehdi Khourssaji, Alaa Beshir, Elodie Collinge
Acquired glucose-6-phosphate dehydrogenase deficiency after allogeneic stem-cell transplantation. EJHaem 5 (4) (2024)
Marie Røra, Margrete Skretting Solberg, Kari Lenita Falck Moore, Tobias Schmidt Slørdahl
Incidence and prevention of skeletal-related events in multiple myeloma patients: A population-based real-world experience. EJHaem 5 (4) (2024)
Jordan Burgess, Fraser Hendry, Catherine N Bagot, Brian Doherty
Catastrophic venous and arterial thrombosis in a young female with cervical cancer. EJHaem 5 (4) (2024)
Maciej Tatarczuch, Katharine Louise Lewis, Ashray Gunjur, Briony Shaw, Limei Michelle Poon, Erin Paul, Matthew Ku, Mark Wong, Sylvia S Y Ai, Ashley Beekman, Pietro R Di Ciaccio, Michael Krigstein, Joel C Wight, Caitlin Coombes, Michael Gilbertson, Amanda Tey, Jake Shortt, Chandramouli Nagarajan, Dipti Talaulikar, Nada Hamad, Sumita Ratnasingam, Shir Jing Ho, Tara Cochrane, Eliza A Hawkes, Chan Yoon Y Cheah, Stephen Samuel Opat, Gareth Peter Gregory
Sequential high-dose methotrexate and cytarabine administration improves outcomes in real-world patients with primary central nervous system lymphoma: A report from the Australasian Lymphoma Alliance. EJHaem 5 (4) (2024)
Roger Kou, Lucy Zhao, Daniel Tham, Rachael Principato, Giovanna Schünemann, Aqib Mannan, Mark Crowther
Fostamatinib for immune thrombocytopenic purpura in adult patients: A systematic review and meta-analysis. EJHaem 5 (4) (2024)
Jieling Jiang, Xiaofan Li, Dong Wu, Quanyi Lu, Kourong Miao, Houcai Wang, Xiaoping Li, Yingnian Chen, Shiyuan Zhou, Yali Zhou, Guiping Liao, Chuanhe Jiang, Xiaohong Yuan, Youshan Zhao, Chunkang Chang, Jie Chen, Han Zhu, Ruye Ma, Nainong Li, Xiao-Lin Yin, Xiao-Jin Wu, Sanbin Wang, Chun Wang, Jiong Hu
Fludarabine, busulfan, and melphalan conditioning regimen in allogeneic hematopoietic stem cell transplantation for adult patients with myeloid malignancies: A multicenter retrospective study. EJHaem 5 (4) (2024)
Abdullah N M Alqahtani, Sandrine Jayne, Matthew J Ahearne, Christopher S Trethewey, Sai S Duraisingham, Susann Lehmann, Caroline M Cowley, Martin J S Dyer, Harriet Sarah Walter
Monitoring of molecular responses to tirabrutinib in a cohort of exceptional responders with relapsed/refractory mantle cell lymphoma. EJHaem 5 (4) (2024)
Lorenzo Cillo, Anna Benedetta Dalla Palma, Stefania Ricci, Mario Pedrazzoni, Matteo Scita, Matia Bernardi, Gabriella Sammarelli, Laura Pelagatti, Nicola Giuliani
Identification of clinical-biological features of newly diagnosed early relapse multiple myeloma patients eligible for autologous stem cell transplantation. EJHaem 5 (4) (2024)
Kevin G Zablonski, Aarthi Rajkumar, Lalitha Nayak
Intravenous Immunoglobulin offers temporary improvement in acquired von Willebrand syndrome due to monoclonal gammopathy: A case report. EJHaem 5 (4) (2024)
Sara Abdelrahim, Glory H Thai, Juanita Burke, Timothy O'Brien, Mohammad Q Ansari, Chen Zhao, Hany Sakr
CD4+ chronic lymphocytic leukemia in an 86-year-old male veteran: A case report. EJHaem 5 (4) (2024)
Erik Boberg, Adrian Kimiaei, Cecilia Karlström, Maria Ljungqvist, Anna Ågren, Maria Bruzelius
Iatrogenic hemorrhage and extensive venous thromboembolism during iTTP treatment with caplacizumab-A case report. EJHaem 5 (4) (2024)
Yui Niiyama-Uchibori, Shinsuke Mizutani, Taku Tsukamoto, Haruya Okamoto, Daisuke Ide, Akio Onishi, Daishi Kato, Takahiro Fujino, Yuji Shimura, Aya Miyagawa-Hayashino, Eiichi Konishi, Kennosuke Karube, Yasuhito Nannya, Junya Kuroda
Small cell pattern of ALK-negative anaplastic large cell lymphoma with double-hit rearrangements of DUSP22 and TP63 . EJHaem 5 (4) (2024)
Ashwin Kannan, Ying Zhuo, Rahul Banerjee
Dramatically elevated plasma vascular endothelial growth factor levels from influenza A infection in polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes syndrome: A case report. EJHaem 5 (4) (2024)
Christian Sebastian Michel, Eva Marie Fehr, Hildegard Nolte, Joachim Beck, Andreas Kreft, Katharina Theresa Rauschkolb-Olk, Bjoern Jacobi, Matthias Theobald, Markus Munder
Effective treatment of refractory monoclonal gammopathy-associated pure red cell aplasia with isatuximab, pomalidomide and dexamethasone. EJHaem 5 (4) (2024)
Masanori Aoki, Maho Ishikawa, Tsugumi Sato, Yoshitada Taji, Hidekazu Kayano, Naoki Takahashi, Yasuhiro Ebihara
Effective treatment of relapsed/refractory CD19-positive B/T-type mixed-phenotype acute leukemia with blinatumomab: A case report. EJHaem 5 (4) (2024)
Khai Li Chai, Cameron Wellard, Ltp Thao, Naomi Aoki, Elizabeth M Moore, Bradley M Augustson, Akshay Bapat, Hilary Blacklock, Wee J Chng, Rachel Cooke, Cecily J Forsyth, Yeow-Tee Goh, Nada Hamad, Simon J Harrison, P Joy Ho, Jay Hocking, Ian Kerridge, Jin Seok Kim, Kihyun Kim, Tracy King, Georgia J McCaughan, Peter Mollee, C Orla Morrissey, Nick Murphy, Hang Quach, Xuan Ni Tan, Allison Ching Yee Tso, Kimberly Sq Wong, Sung Soo Yoon, Andrew Spencer, Erica M Wood, Zoe K McQuilten
Variation in immunoglobulin use and impact on survival in myeloma. EJHaem 5 (4) (2024)
Michael J R Desborough, Emma Laing, Daphne Kounali, Ana Mora, Renate Hodge, Siobhan Martin, Helen Thomas, Cara Hudson, Joseph Parsons, Akshay Shah, Paula Hutton, Tim Parke, Matthew P Wise, Matthew Morgan, Stuart McKechnie, Simon J Stanworth
Desmopressin for prevention of bleeding for thrombocytopenic, critically ill patients undergoing invasive procedures: A randomised, double-blind, placebo-controlled feasibility trial. EJHaem 5 (4) (2024)
Tomohiro Yabushita, Yoshimitsu Shimomura, Hayato Maruoka, Daisuke Katoh, Daisuke Yamashita, Hironaga Satake, Nobuhiro Hiramoto, Satoshi Yoshioka, Noboru Yonetani, Momoko Nishikori, Takeshi Morimoto, Yukihiro Imai, Takayuki Ishikawa
Complete detection of FR1 to FR3 primer-based PCR patterns of immunoglobulin heavy chain rearrangement in the BIOMED-2 protocol is associated with poor prognosis in patients with diffuse large B-cell lymphoma. EJHaem 5 (4) (2024)
Hineptch Daungsupawong, Viroj Wiwanitkit
Comment on "Severe acute respiratory syndrome coronavirus 2 infection in patients with hematological malignancies in the Omicron era: respiratory failure, need for mechanical ventilation and mortality in seronegative and seropositive patients". EJHaem 5 (4) (2024)
Khai Li Chai, Cameron Wellard, Ltp Thao, Naomi Aoki, Elizabeth M Moore, Bradley M Augustson, Akshay Bapat, Hilary Blacklock, Wee J Chng, Rachel Cooke, Cecily J Forsyth, Yeow-Tee Goh, Nada Hamad, Simon J Harrison, P Joy Ho, Jay Hocking, Ian Kerridge, Jin Seok Kim, Kihyun Kim, Tracy King, Georgia J McCaughan, Peter Mollee, C Orla Morrissey, Nick Murphy, Hang Quach, Xuan Ni Tan, Allison Ching Yee Tso, Kimberly Sq Wong, Sung Soo Yoon, Andrew Spencer, Erica M Wood, Zoe K McQuilten
Variation in immunoglobulin use and impact on survival in myeloma. EJHaem 5 (4) (2024)
Vadim Lesan, Ketevani Melivadze, Johannes Hein, Manfred Ahlgrimm, Stefan Schunk, Moritz Bewarder, Konstantinos Christofyllakis, Joerg Thomas Bittenbring, Lorenz Thurner
Successful treatment of refractory donor-specific-human leukocyte antigen-antibody-induced primary graft-failure with daratumumab: A case report. EJHaem 5 (4) (2024)
Christian Sebastian Michel, Eva Marie Fehr, Hildegard Nolte, Joachim Beck, Andreas Kreft, Katharina Theresa Rauschkolb-Olk, Bjoern Jacobi, Matthias Theobald, Markus Munder
Effective treatment of refractory monoclonal gammopathy-associated pure red cell aplasia with isatuximab, pomalidomide and dexamethasone. EJHaem 5 (4) (2024)
Gulser Caliskan, Yudi Pawitan, Trung Nghia Vu
Similarities and differences of bone marrow and peripheral blood samples from acute myeloid leukemia patients in terms of cellular heterogeneity and ex-vivo drug sensitivity. EJHaem 5 (4) (2024)
Chien-Chin Lin, Chi-Yuan Yao, Yuan-Yeh Kuo, Yueh-Chwen Hsu, Chang-Tsu Yuan, Tsung-Chih Chen, Chia-Lang Hsu, Sze-Hwei Lee, Jhih-Yi Lee, Pin-Tsen Shih, Chein-Jun Kao, Po-Han Chuang, Yuan-Yeh Kuo, Hsin-An Hou, Wen-Chien Chou, Hwei-Fang Tien
IDH2 mutation accelerates TPO-induced myelofibrosis with enhanced S100a8/a9 and NFκB signaling in vivo. EJHaem 5 (4) (2024)
Michael Richard Grunwald, Ellen K Ritchie, Elisa Rumi, Albert Assad, J E Hamer-Maansson, Jingbo Yu, Tricia Kalafut, Evan Braunstein, Francesco Passamonti
Treatment comparison of hydroxyurea versus ruxolitinib in essential thrombocythaemia: A matched-cohort analysis. EJHaem 5 (4) (2024)
Anna Nikkarinen, Ingrid Glimelius
Aplastic anemia triggered by the Bruton tyrosine kinase inhibitor acalabrutinib in two patients with mantle cell lymphoma - A case report. EJHaem 5 (4) (2024)
Justin Penner, James E Burns, Judith Breuer, Kimberly C Gilmour, Alasdair Bamford, Anupama Rao
Case series: Congenital enterovirus infection-associated haemophagocytic lymphohistiocytosis and subsequent neutropaenia. EJHaem 5 (4) (2024)
Zekarias Seifu Ayalew, Gebeyehu Tessema Azibte, Fisihatsion Tadesse, Biruk Abate Legesse, Zerubabel Getahun Kiflu, Mahlet Tsige Weldeamanuel, Kibrekidusan Aynekulu Tsige, Bereket Abraha Molla, Addisu Melkie Ejigu
Unveiling the nephrotoxic profile of BCR-ABL tyrosine kinase inhibitors: A real-world experience in Africa. EJHaem 5 (4) (2024)
Kevin C Graf, James A Davis, Alyssa Cendagorta, Katelynn Granger, Kelly J Gaffney, Kimberly Green, Brian T Hess, Hamza Hashmi
"Fast but not so furious" : A condensed step-up dosing schedule of teclistamab for relapsed/refractory multiple myeloma. EJHaem 5 (4) (2024)
Kosuke Obama, Hana Yamamoto, Hirosaka Inoue
Sequential treatment with valemetostat and conventional anti-cancer drugs for refractory aggressive adult T-cell leukemia/lymphoma: A case report. EJHaem 5 (4) (2024)
Richard John Buka, Mamidipudi T Krishna, David J Sutton
Fatal drug reaction to andexanet alfa: a case report. EJHaem 5 (4) (2024)
Ariane Le Clainche Compagnie, Charlotte Degoutte, Barbara Papouin, Claire Lamaison, Romain Gounot, Saskia Ingen-Housz-Oro
Asteatotic eczema, a cutaneous manifestation of Hodgkin lymphoma in older patients. EJHaem 5 (4) (2024)
Sam Sherratt-Mayhew, Phillip Lindsay Ross Nicolson
Use of IV immunoglobulin to treat steroid resistant, immune checkpoint inhibitor-induced pure red cell aplasia: A case report. EJHaem 5 (4) (2024)
Michael J R Desborough, Emma Laing, Daphne Kounali, Ana Mora, Renate Hodge, Siobhan Martin, Helen Thomas, Cara Hudson, Joseph Parsons, Akshay Shah, Paula Hutton, Tim Parke, Matthew P Wise, Matthew Morgan, Stuart McKechnie, Simon J Stanworth
Desmopressin for prevention of bleeding for thrombocytopenic, critically ill patients undergoing invasive procedures: A randomised, double-blind, placebo-controlled feasibility trial. EJHaem 5 (4) (2024)
Maria Papatsirou, Christos K Kontos, Ioannis Ntanasis-Stathopoulos, Panagiotis Malandrakis, Foteini Theodorakakou, Christine-Ivy Liacos, Nefeli Mavrianou-Koutsoukou, Despina Fotiou, Magdalini Migkou, Maria Gavriatopoulou, Efstathios Kastritis, Meletios- Athanasios Dimopoulos, Andreas Scorilas, Evangelos Terpos
ciRS-7 circular RNA overexpression in plasma cells is a promising molecular biomarker of unfavorable prognosis in multiple myeloma. EJHaem 5 (4) (2024)
David C Gajzer, Xueyan Chen, Daniel E Sabath, Christina Poh, Kikkeri N Naresh
Does a subset of mature T-cell leukemias with features akin to T-cell prolymphocytic leukemia but lacking rearrangement of the TCL1 represent peripheral T-cell lymphoma, NOS in a leukemic phase? EJHaem 5 (4) (2024)
Vania Tietsche de Moraes Hungria, Camila Peña, Guillermo José Ruiz Argüelles, Humberto Martínez-Cordero, Natalia Paola Schütz, Vivian Blunk
Multiple myeloma in Latin America: A systematic review. EJHaem 5 (4) (2024)
Syed Naqvi, Asis Shrestha, Marah Alzubi, Jawad Alrawabdeh, Sharmilan Thanendrarajan, Maurizio Zangari, Frits van Rhee, Carolina Schinke, Samer Al Hadidi
Weight loss and dysgeusia in relapsed/refractory multiple myeloma patients treated with talquetamab. EJHaem 5 (4) (2024)
Cyrille Hulin, Nadia Quignot, Heng Jiang, Hakima Mechiche, Gaëlle Désaméricq
Carfilzomib use in patients with relapsed/refractory multiple myeloma in France: A national retrospective cohort study. EJHaem 5 (4) (2024)
Vania Tietsche de Moraes Hungria, Camila Peña, Guillermo José Ruiz Argüelles, Humberto Martínez-Cordero, Natalia Paola Schütz, Vivian Blunk
Multiple myeloma in Latin America: A systematic review. EJHaem 5 (4) (2024)
Syed Naqvi, Asis Shrestha, Marah Alzubi, Jawad Alrawabdeh, Sharmilan Thanendrarajan, Maurizio Zangari, Frits van Rhee, Carolina Schinke, Samer Al Hadidi
Weight loss and dysgeusia in relapsed/refractory multiple myeloma patients treated with talquetamab. EJHaem 5 (4) (2024)
Anna Nikkarinen, Ingrid Glimelius
Aplastic anemia triggered by the Bruton tyrosine kinase inhibitor acalabrutinib in two patients with mantle cell lymphoma - A case report. EJHaem 5 (4) (2024)